Drawing for Serial No. 99712895

USPTO serial 99712895

Serial No. 99712895

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
Examiner
WOOD, DANIEL PAUL
Law office
TMO LAW OFFICE 128

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 99712895?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony E. Bennett

Anthony E. Bennett Hoffmann & Baron, LLP6900 Jericho TurnpikeSyosset, NY 11793United States

Goods and services

ClassDescriptionStatusFirst use
016Printed publications, namely, magazines in the field of immunotherapy; Printed posters; Printed pamphlets in the field of immunotherapy; Printed informational flyers and leaflets featuring information regarding immunotherapy; Printed newspapers; Printed matter in the nature of manual handbooks in the field of immunotherapy; Printed booklets in the field of immunotherapy; Printed magazines and journals featuring information about immunotherapy; Printed instructional and teaching material in the field of immunotherapyACTIVE
035Advertising and marketing services; Providing consumer product information regarding medical products to patients and healthcare professionals; Advertising and marketing services featuring medical goods, medical testing and diagnostic products and services; Market research; Business strategy development services; Business planning; Business data analysis; Business management; Business organization consulting; Business administration; Retail store services, online retail store services, and wholesale store services featuring transdermal patches, skin patches and adhesive skin patches for medical use, transdermal and adhesive skin patches for treating, alleviating and preventing the development and progression of allergies and immunological disorders, transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals and medical preparations, patches and epicutaneous systems for the cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, adhesive patches and adhesive epicutaneous systems for cutaneous and epicutaneous administration of medical and pharmaceutical substances for treating allergies and immunological disorders, occlusive patches and occlusive epicutaneous systems for cutaneous and epicutaneous administration of powdered medical and pharmaceutical substances for treating allergies and immunological disorders, patches and epicutaneous systems containing a powdered preparation for medical and pharmaceutical use for treating allergies and immunological disorders, patches and epicutaneous systems for use in the treatment of allergies and immunological disorders, patches and epicutaneous systems featuring allergens and antigens for treating allergies and immunological disorders, allergy medication, pharmaceutical preparations for treating allergies, pharmaceutical preparations for treating food allergies; Retail store services, online retail store services and wholesale store services connected with the sale of medical instruments, apparatus and devices for the cutaneous, epicutaneous and patch-based administration and delivery of medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for receiving, holding and containing medical and pharmaceutical substances for the treatment, alleviation and prevention of allergies and immunological disorders, pads and skin patches for medical training purposes, pads and skin patches for medical use, namely, for use in training medical professionals on the transdermal delivery of pharmaceuticals and medical preparations, medical instruments, apparatus and devices sold without medication for the later administration, by cutaneous and epicutaneous means, of medical and pharmaceutical substances, pad, skin patch and occlusion patch dispensers and applicators for medical use; advisory, information and consultancy services relating to all of the aforesaidACTIVE
041Training services for consumers and medical professionals in the field of allergies and immunotherapy; Provision of classes, seminars, educational programs, educational conferences, congresses, and workshops in the field of allergies and immunotherapy; Organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of allergies and immunotherapy; Publication of periodicals, books, and catalogs in the fields of allergies and immunotherapy; information, advisory and consultancy services relating to all of the aforesaidACTIVE
042Medical and scientific research in the fields of allergies and immunotherapy; Development services of scientific methods for cutaneous and epicutaneous immunotherapy; Medical and scientific research relating to the treatment, alleviation and prevention of autoimmune, infectious and inflammatory diseases; Medical and scientific research in the fields of allergy treatment and care; Allergenic drug discovery services; Medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and the skin; Medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' skin; information, advisory and consultancy services relating to all of the aforesaidACTIVE
044Medical services relating to the treatment, alleviation and prevention of allergies; medical treatment, alleviation and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical and pharmaceutical substances, allergens and antigens using patches affixed to patients' skin; medical consultancy in the field of desensitization to allergies; providing medical information regarding medical conditions, allergies, intolerances, treatments and products to patients and healthcare professionals; provision of medical advice to patients and healthcare professionals regarding medical conditions, allergies, intolerances and treatment; providing medical information regarding medical products to patients and healthcare professionals; information, advisory and consultancy services relating to all of the aforesaidACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2026DOCKASSIGNED TO EXAMINER
May 18, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
May 18, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Mar 19, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance